Focus
View

ARROWHEAD PHARMACEUTICALS, INC.

ARWR · FY2025

ALIGNED

CEO Package

$9.0M

Pay Ratio

—

Christopher Anzalone

Pay reset -27.3% while TSR improved +292 pts

JOHNSON & JOHNSON

JNJ · FY2025

ALIGNED

CEO Package

$32.8M

Pay Ratio

—

J. Duato

Returns outran pay growth by +16.0 pts

ELI LILLY & Co

LLY · FY2025

ALIGNED

CEO Package

$30.2M

Pay Ratio

—

David A. Ricks

Returns outran pay growth by +3.5 pts

CEO Total Compensation — All Companies

ARWR$9.0MJNJ$32.8MLLY$30.2M

All values are grant-date fair value as reported in proxy statements.

Key Differences

The fastest way to read this comparison before dropping into the tables.

JNJ carries the largest package at $32.8M, about 3.6x ARWR.

Pay Component Breakdown

Latest CEO package mix by company. This stays on the CEO package even if the chart above is showing Top 5 pay.

ARWR

Christopher Anzalone

$9.0M

base salary11%
stock awards75%
non-equity incentive compensation14%
other compensation0%

JNJ

J. Duato

$32.8M

base salary5%
stock awards46%
option awards18%
non-equity incentive compensation13%
other compensation2%

LLY

David A. Ricks

$30.2M

base salary6%
stock awards77%
other compensation2%

Quick Comparison

CompanyCEOLatest YearTotal Comp
ARROWHEAD PHARMACEUTICALS, INC.(ARWR)Christopher Anzalone2025$9.0M
JOHNSON & JOHNSON(JNJ)J. Duato2025$32.8M
ELI LILLY & Co(LLY)David A. Ricks2025$30.2M

Note: All compensation values shown are grant-date fair value as reported in proxy statements. Direct comparisons should account for differences in company size, industry, and compensation structure.

Want to know when these numbers change?

We’ll email you when these companies file a new proxy — so you can see how CEO pay, equity awards, and ratios shift before the next headline.